Two New Cancer Drugs Approved
The US Food and Drug Administration (FDA) has approved two new medications for cancer.
Approved: A New Rx for Liposarcoma
This week, the US Food and Drug Administration (FDA) approved Eisai Inc.'s drug derived from sea sponge for a rare type of soft tissue cancer.
FDA Approves New Liposarcoma Rx
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.
Cancer Meds in 2015: A Year in Review
This year was a big one for cancer treatment.
Towards New Treatments for Infant Cancer
Babies can be born with cancer that developed in the mother’s womb. One such cancer is a disease with a long name: infantile myofibromatosis (IM).
Microwaving Away Pain
Cancer that either starts in or spreads to the bone can be extremely painful. So can cancers that begin in the muscles or other soft tissue of the body. A relatively new treatment method may bring much needed relief.
Cancer Dictates Final Fate of Hugo Chavez
After a rigorous battle, Venezuelan president Hugo Chavez has died of cancer. He was 58. Chavez recently returned from Cuba, where he received the fourth and final surgery for cancer described imprecisely as “pelvic cancer.”
FDA Approves New GIST Rx
The US Food and Drug Administration has approved a medication to treat gastrointestinal stromal tumors (GIST) that can’t be removed with surgery, have spread or no longer respond to existing therapies.
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors
The US Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
Children With Leukemia Have New Rx
Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.